Skip to main content
MedPathMedPath Home
Clinical Trials/PACTR202408912454189
PACTR202408912454189
Completed
Phase 1

Effect of Home Blood Pressure Telemonitoring on hypertension control rate and drug adherence in Kenya: an interventional study (HBPT-K)

uscii App0 sites100 target enrollmentAugust 5, 2024
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCirculatory SystemNutritional, Metabolic, EndocrineCardiology

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Circulatory System
Sponsor
uscii App
Enrollment
100
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 5, 2024
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
uscii App

Eligibility Criteria

Inclusion Criteria

  • •Age \=18 years
  • •\- Confirmed hypertension with BP\>140/90 mmHg
  • •\- Own or have access to a smartphone with internet access throughout the study
  • •\- Able to provide written informed consent prior to participation in the study

Exclusion Criteria

  • •\- Persistent atrial fibrillation as indicated in the health record
  • •\- Pregnant or planning to become pregnant during the study period
  • •\- Severe kidney disease, defined as estimated glomerular filtration rate \<30 per
  • •1\.73 m2 or currently on renal replacement therapy (i.e., hemodialysis or
  • •peritoneal dialysis)
  • •\- Recent cardiovascular event (ischemic stroke, transient ischemic attack,
  • •myocardial infarction, coronary artery bypass grafting) in the past 3 months
  • •\- Diagnosis of dementia or psychosis as indicated in the health record
  • •\- Life expectancy \<1 year, for instance in terminal cancer or NYHA III or IV
  • •heart failure

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Effectiveness of Home-monitoring of Blood Pressure in Patients with Therapy Resistant HypertensioHypertension
NL-OMON27683.A.200
Completed
Not Applicable
A Study of a Hypertensive Population Under Treatment With Micardis® and Micardis Plus® to Control the Early Morning BP Rise (SURGE II)Hypertension
NCT02242396Boehringer Ingelheim5,248
Completed
Not Applicable
The importance of home blood pressure in patients with diabetes.diabetes mellitus
JPRN-UMIN000018581Kyoto Prefectural University of Medicine, Graduate School of Medical Science50
Completed
Not Applicable
Fimasartan Optimal Reduction Targeting Elevated Blood Pressure: the FORTE StudyHypertension
NCT03254914Boryung Pharmaceutical Co., Ltd3,554
Completed
Not Applicable
A Home-based Blood Pressure Monitoring Program to Promote Better Management of HypertensionHypertension
NCT01525108Tehran University of Medical Sciences196